DNAnexus: Stephen Nuckols

DNAnexus has named Stephen Nuckols chief commercial officer to direct the company's growth strategy, sales, and marketing efforts following a $200 million financing round that closed earlier this year. Nuckols previously served as chief revenue officer of drug development software company ArisGlobal. Before ArisGlobal, he was executive VP and chief commercial officer of ERT, a clinical trial services firm that later merged with Bioclinica to form Clario.